Brenntag has announced a new strategic partnership with K+S Minerals and Agriculture – a globally oriented raw materials company – for the worldwide distribution of three pharmaceutical salts.
Philipp Markolin, scientific marketing manager at peptide and oligonucleotide manufacturers Bachem, shares his insights on the latest innovations in sustainable oligonucleotide manufacturing to boost efficiency and reduce waste.
Beth Tran, global business manager, CR Excipients, Colorcon, explains how innovations in controlled release systems, film coatings and functional excipients are driving the future of drug delivery.
David Blanco, Industrial BD & CDMO director, Suanfarma, shares how the pharma industry can enhance innovation by combining biofermentation and chemical synthesis, while highlighting the importance of technology transfer for implementation of both.
WuXi AppTec have announced the commissioning of two new peptide manufacturing plants, one at its Changzhou facility and another at the new Taixing site in China.
Peter Freed, Head of Global Pharma Customer Technical Support at Roquette breaks open mannitol, the mighty molecule, and takes a closer look at some of its underrepresented functionalities.
Egis Pharmaceuticals is expanding its usual activities with new elements thanks to investments exceeding a total value of more than 100 billion HUF in Hungary over the past period.
Catherine Wilkes, Executive Director of Environmental, Health and Safety at Quotient Sciences explores how containment protocols shift when dealing with HPAPIs to meet the required safety standards.
François Rieger, CEO, and Carole Nicco, Chief Scientific Officer, BioSenic, looks at the use of Arsenic as a novel API as a companion piece to our latest EPM Issue.
